Environmental toxin exposure represents a significant modifiable risk factor in the pathogenesis of atypical parkinsonism, including Progressive Supranuclear Palsy (PSP), Corticobasal Syndrome (CBS), and Parkinson's Disease. While genetic factors, particularly the MAPT H1 haplotype and GBA variants, establish baseline susceptibility, environmental exposures can trigger or accelerate neurodegenerative processes through mitochondrial dysfunction, oxidative stress, neuroinflammation, and protein aggregation pathways.
This page synthesizes current evidence linking environmental toxins to atypical parkinsonism, with particular focus on mechanisms relevant to tauopathies and α-synucleinopathies. For general environmental risk factors across neurodegenerative diseases, see Environmental Risk Factors for Neurodegeneration.
Rotenone is a naturally occurring pesticide derived from the roots of certain plants (Derris, Lonchocarpus) and has been used in organic farming and fish farming. It is a potent mitochondrial complex I inhibitor that has been extensively studied in relation to parkinsonism.
Mechanisms of Neurotoxicity:
Epidemiological Evidence:
Relevance to Atypical Parkinsonism:
Paraquat (1,1'-dimethyl-4,4'-bipyridinium) is a widely used herbicide structurally similar to the nigrostriatal toxin MPTP. Despite restricted use in many countries, paraquat remains extensively used globally.
Mechanisms of Neurotoxicity:
Epidemiological Evidence:
Relevance to Atypical Parkinsonism:
Organophosphates constitute the most widely used pesticide class, including compounds such as chlorpyrifos, diazinon, and malathion. Their neurotoxicity is primarily through acetylcholinesterase inhibition.
Mechanisms of Neurotoxicity:
Epidemiological Evidence:
Pyrethroids are synthetic insecticides that constitute a major pesticide class. While generally considered safer than organophosphates, emerging evidence suggests neurotoxicity at chronic exposure levels.
Mechanisms of Neurotoxicity:
Epidemiological Evidence:
Trichloroethylene is a chlorinated solvent used in degreasing, dry cleaning, and industrial applications. It has been linked to parkinsonism through multiple case reports and occupational studies.
Mechanisms of Neurotoxicity:
Epidemiological Evidence:
Relevance to Atypical Parkinsonism:
Perchloroethylene (tetrachloroethylene) is the primary dry cleaning solvent. Occupational exposure occurs among dry cleaning workers.
Mechanisms of Neurotoxicity:
Epidemiological Evidence:
Benzene, toluene, and xylene exposure occurs in various occupational settings. These solvents have been associated with:
Fine particulate matter (PM2.5, particles ≤2.5 μm diameter) has emerged as a significant environmental risk factor for neurodegenerative diseases.
Mechanisms of Neurotoxicity:
Epidemiological Evidence:
Relevance to Atypical Parkinsonism:
Traffic-related air pollution, including nitrogen dioxide and ground-level ozone, has been associated with:
Manganese is essential for normal brain function but becomes neurotoxic at elevated levels. Occupational exposure to manganese fumes occurs among welders, steelworkers, and battery manufacturers.
Mechanisms of Neurotoxicity:
Clinical Presentation:
Relevance to Atypical Parkinsonism:
Iron accumulation is a hallmark of several neurodegenerative disorders, including PSP, PD, and AD.
Mechanisms of Neurotoxicity:
Relevance to Atypical Parkinsonism:
Lead is a potent neurotoxin that accumulates in bone and brain tissue over decades of exposure.
Mechanisms of Neurotoxicity:
Epidemiological Evidence:
Copper dysregulation contributes to neurodegeneration through multiple pathways:
Glucocerebrosidase (GBA) variants are the most significant genetic risk factors for Parkinson's disease and are also associated with worse outcomes in atypical parkinsonism.
LRRK2 mutations are a major cause of familial PD. Environmental factors may modify risk in LRRK2 carriers:
The MAPT H1 haplotype is the strongest genetic risk factor for PSP. Environmental factors may interact with tau pathology:
Clinicians should assess environmental exposures in patients with atypical parkinsonism:
| Exposure Category | Key Questions |
|---|---|
| Pesticides | Have you worked in agriculture or applied pesticides? What specific products? |
| Solvents | Have you worked as a painter, dry cleaner, or in degreasing operations? |
| Heavy metals | Have you worked as a welder, battery worker, or miner? |
| Residence | Have you lived near industrial sites or areas with heavy pesticide use? |
While direct biomarker assessment of toxin exposure is limited:
Last updated: 2026-03-24
Betarbet R, et al. Rotenone model of Parkinson's disease. Environmental Health Perspectives. 2000. ↩︎
Sherer TB, et al. Rotenone and alpha-synuclein. Journal of Neuroscience. 2003. ↩︎
Cicchetti F, et al. Neuroinflammation, Parkinson's disease and pesticides. Canadian Journal of Neurological Sciences. 2005. ↩︎
Johnson ME, et al. Rotenone model of gastrointestinal dysfunction. Neurobiology of Disease. 2012. ↩︎
Tanner CM, et al. Rotenone, paraquat and Parkinson's disease. Environmental Health Perspectives. 2011. ↩︎
Cochemé HM, et al. Paraquat is not a mitochondrial toxin. Nature. 2011. ↩︎
Liou HH, et al. Paraquat and dopaminergic neuron degeneration. Brain Research. 1997. ↩︎
Kearney PC, et al. Paraquat meta-analysis. Neurotoxicology. 2023. ↩︎
Slotkin TA, et al. Organophosphates and neurodevelopment. Toxicology and Applied Pharmacology. 2005. ↩︎
Kou J, et al. Chronic organophosphate exposure and neurodegeneration. Neurochemistry International. 2019. ↩︎
而上原 M, et al. Pyrethroid neurotoxicity mechanisms. Neurotoxicology. 2020. ↩︎
Gash DM, et al. Trichloroethylene: Parkinsonism and dopaminergic toxicity. Neurotoxicology. 2008. ↩︎
Goldman SM, et al. Trichloroethylene and parkinsonism. Neurology. 2015. ↩︎
Ritz SA, et al. Perchloroethylene exposure and neurodegeneration. Environmental Health Perspectives. 2000. ↩︎
Koch H, et al. Solvent exposure and neurodegeneration. Journal of Neurology. 2019. ↩︎
Gli S, et al. Olfactory pathway for nanoparticles. Environmental Health Perspectives. 2016. ↩︎
Block ML, et al. Air pollution, microglia and neurodegeneration. Environmental Health Perspectives. 2012. ↩︎
Peters R, et al. Air pollution and dementia. Alzheimer's & Dementia. 2019. ↩︎
Yin F, et al. Air pollution and white matter integrity. Journal of Alzheimer's Disease. 2020. ↩︎
Horning KJ, et al. Manganese and alpha-synuclein. Toxicology and Applied Pharmacology. 2015. ↩︎
Lei Z, et al. Ferroptosis in neurodegenerative diseases. Cellular and Molecular Neurobiology. 2021. ↩︎
Bressler JP, et al. Lead neurotoxicity. Neurochemical Research. 2004. ↩︎
Uversky VN, et al. Metals and alpha-synuclein. European Journal of Biochemistry. 2002. ↩︎
Liu G, et al. GBA and pesticide interaction in Parkinson's disease. Brain. 2017. ↩︎
San Luciano M, et al. LRRK2 and environmental exposures. Parkinsonism & Related Disorders. 2020. ↩︎
Gao L, et al. Environmental risk factors for progressive supranuclear palsy. Journal of Neurology, Neurosurgery & Psychiatry. 2017. ↩︎
Kuhle J, et al. Neurofilament light chain. JAMA Neurology. 2019. ↩︎
Livingston G, et al. Dementia prevention targets. The Lancet. 2017. ↩︎